Rinica Pharma Private Limited
About Rinica Pharma Private Limited
Data last updated:
Rinica Pharma Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India, a subsidiary of Pantson Pharma Private Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 01 August 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2014PTC256823. Its GSTIN is 27AAHCP7662B1ZC (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Pantson Laboratories Private Limited. It is led by directors including Virdeepsinh Lakhdhirsinh Sarvaiya and Monica Pant.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 63 Ttc Industrial Area MIDC Khairane, Navi Mumbai, Maharashtra, India – 400705.
As per the financials filed for FY 2025, the company reported a revenue of ₹70.18 Lakh, a decline of 24% compared to the previous year. For the same year it recorded a net loss of ₹1.12 Cr (net margin -159.1%) and EBITDA of -₹1.11 Cr (EBITDA margin -158%).
The company has about 26 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Rinica Pharma Private Limited's registered office is in Navi Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 63 Ttc Industrial Area MIDC Khairane, Navi Mumbai, Maharashtra, India – 400705
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Rinica Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rinica Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Rinica Pharma Private Limited, buy the company report.
Financials of Rinica Pharma Private Limited
FY 2025 filings availableRinica Pharma Private Limited reported revenue of ₹70.18 Lakh (down 24% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.11 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.12 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -158% | ||||
| Net Profit Margin | -159.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rinica Pharma Private Limited, buy the company report.
Board of directors of Rinica Pharma Private Limited
Rinica Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Virdeepsinh Lakhdhirsinh Sarvaiya Also directs: Neel Nayan Pharma Pvt Ltd | Director | 01 Aug 2014 | 12 Years 2 Months | Current |
| Monica Pant Also directs: Pantson Pharma Private Limited, Neel Nayan Pharma Pvt Ltd, Mihasyu Clinicals Private Limited and 1 more | Director | 04 Mar 2019 | 7 Years 7 Months | Current |
| Urmila Devi Vemula Also directs: Pantson Pharma Private Limited | Director | 01 Jul 2021 | 5 Years 3 Months | Current |
Auditor
Rinica Pharma Private Limited is audited by DIPTI TAPARIA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DIPTI TAPARIA | FY 2023 | 110919 |
Shareholding
The shareholding of Rinica Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Rinica Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rinica Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rinica Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rinica Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCP7662B1ZC | Maharashtra | Active | 17 Jul 2018 |
To see the full GST registrations and return filing status of Rinica Pharma Private Limited, buy the company report.
Recent activity
Rinica Pharma Private Limited has 8 board changes on record since 2014: 4 appointments and 4 cessations. The latest: Mousumi Satyanarayana Vemula ceased to be Director on 01 Jul 2021.
Frequently asked questions
Rinica Pharma is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 01 August 2014 (12+ years old) and is registered under CIN U74999MH2014PTC256823.
Rinica Pharma has 3 current directors:
- Virdeepsinh Lakhdhirsinh Sarvaiya - Director
- Monica Pant - Director
- Urmila Devi Vemula - Director
The latest financial statements of Rinica Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Rinica Pharma is 27AAHCP7662B1ZC, registered in Maharashtra.
The CIN (Corporate Identification Number) of Rinica Pharma is U74999MH2014PTC256823. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rinica Pharma was incorporated on 01 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
Mousumi Satyanarayana Vemula ceased to be Director on 01 Jul 2021. Urmila Devi Vemula was appointed as Director on 01 Jul 2021. Mayank Pant was appointed as CEO on 15 May 2019. Rinica Pharma has 8 board changes on record in total.
The registered office of Rinica Pharma is at A – 63 Ttc Industrial Area MIDC Khairane, Navi Mumbai, Maharashtra, India – 400705.
Rinica Pharma operates in the pharma industry, in the pharma contract r and d segment.
The compliance status of Rinica Pharma is compliant as of 28 September 2026. The company is actively filing with the Registrar of Companies.